Search

Your search keyword '"U618"' showing total 99 results

Search Constraints

Start Over You searched for: Author "U618" Remove constraint Author: "U618"
99 results on '"U618"'

Search Results

1. Secretory Leukocyte Protease Inhibitor (SLPI) Is, like Its Homologue Trappin-2 (Pre-Elafin), a Transglutaminase Substrate

2. French Intensive Care Society, International congress – Réanimation 2016

3. Therapeutic antibodies: A new era in the treatment of respiratory diseases?

4. TFPI-2 silencing increases tumour progression and promotes metalloproteinase 1 and 3 induction through tumour-stromal cell interactions

5. Expression and methylation status of tissue factor pathway inhibitor-2 gene in non-small-cell lung cancer

6. Characterization and functional analysis of TFPI-2 gene promoter in a human choriocarcinoma cell line

7. Fate of inhaled monoclonal antibodies after the deposition of aerosolized particles in the respiratory system

8. Fate of inhaled monoclonal antibodies after the deposition of aerosolized particles in the respiratory system

9. Characterisation of a cysteine protease expressed by Eimeria tenella and identification of its post-traductionnal regulator

10. La Kallicréine tissulaire 12, une kallicréine génératrice de kinines ?

11. Is human kallikrein related peptidase 12 (KLK12), a novel kininogenase?

12. Human cysteine cathepsins are not reliable markers of infection by Pseudomonas aeruginosa in cystic fibrosis

13. Charactérisation des protéases à cystéine exprimées par le parasite Eimeria tenella

14. Feasibility study of teicoplanin nebulization during mechanical ventilation

15. Teicoplanin Aerosol In Mechanical Ventilated Piglets: Lung Deposition And Pharmacokinetic Study

16. Development of an ELISA for quantifying egg white ovalbumin-related protein X (OVAX)

17. Kallikrein-related peptidase 12 hydrolyzes matricellular proteins of the CCN family and modifies interactions of CCN1 and CCN5 with growth factors

18. Antimicrobial potential of egg Yolk ovoinhibitor, a multidomain Kazal-like inhibitor of chicken egg

19. Identification of regulatory CCN proteins as substrates for kallikrein-related peptidase 12: functional implications of proteolysis

20. Effect of the oligodendrocyte myelin glycoprotein (OMgp) on the expansion and neuronal differentiation of rat neural stem cells

21. Identification of neutralizing conformational epitopes on the human papillomavirus type 31 major capsid protein and functional implications

22. Improved PCR Method for Amplification of GC-Rich DNA Sequences

23. Computer model of the interaction of human TFPI-2 Kunitz-type serine protease inhibitor with human plasmin

24. Étude des propriétés de transglutamination de deux inhibiteurs des protéases à sérine de neutrophile à potentiel thérapeutique

25. The chicken miR-150 targets the avian orthologue of the functional zebrafish MYB 3'UTR target site

26. A candidate gene study identifies a haplotype of CD2 as novel susceptibility factor for systemic sclerosis.

27. Identification of NF-κB and PLCL2 as new susceptibility genes and highlights on a potential role of IRF8 through interferon signature modulation in systemic sclerosis.

28. Air contamination around patients colonized with multidrug-resistant organisms.

29. Monitoring of tumour progression using bioluminescence imaging and computed tomography scanning in a nude mouse orthotopic model of human small cell lung cancer.

30. Cysteine cathepsins S and L modulate anti-angiogenic activities of human endostatin.

31. SLPI and trappin-2 as therapeutic agents to target airway serine proteases in inflammatory lung diseases: current and future directions.

32. Asthma unmasked with tumor necrosis factor-α-blocking drugs.

33. The airways, a novel route for delivering monoclonal antibodies to treat lung tumors.

35. High levels of antibodies against merkel cell polyomavirus identify a subset of patients with merkel cell carcinoma with better clinical outcome.

36. TFPI-2 silencing increases tumour progression and promotes metalloproteinase 1 and 3 induction through tumour-stromal cell interactions.

37. Shrinking lung syndrome: recognition, pathophysiology and therapeutic strategy.

38. Secretory leukocyte protease inhibitor (SLPI) is, like its homologue trappin-2 (pre-elafin), a transglutaminase substrate.

39. [Respimat®, first Soft Mist™ inhaler: new perspectives in the management of COPD].

40. Kininogens: More than cysteine protease inhibitors and kinin precursors.

41. Phage display as a powerful tool to engineer protease inhibitors.

42. Investigation of the prevalence of antibodies against neurotropic polyomaviruses BK, JC and SV40 in sera from patients affected by multiple sclerosis.

43. The occluding loop of cathepsin B prevents its effective inhibition by human kininogens.

44. Generation of Merkel cell polyomavirus (MCV)-like particles and their application to detection of MCV antibodies.

45. Papillomavirus pseudovirions packaged with the L2 gene induce cross-neutralizing antibodies.

46. Evaluation of lung tolerance of ethanol, propylene glycol, and sorbitan monooleate as solvents in medical aerosols.

47. Structural characterization of mouse neutrophil serine proteases and identification of their substrate specificities: relevance to mouse models of human inflammatory diseases.

48. Catalytic activity and inhibition of wegener antigen proteinase 3 on the cell surface of human polymorphonuclear neutrophils.

49. Identification of neutralizing conformational epitopes on the human papillomavirus type 31 major capsid protein and functional implications.

50. Voltage-gated Sodium Channel Activity Promotes Cysteine Cathepsin-dependent Invasiveness and Colony Growth of Human Cancer Cells.

Catalog

Books, media, physical & digital resources